{
    "title": "RSS Feed Title",
    "link": "https://example.com",
    "description": "RSS Feed Description",
    "lastBuildDate": "2025-05-06T05:45:54.844495",
    "items": [
        {
            "title": "TPG seals deal to acquire 35% stake in Serum Institute-SCHOTT Pharma JV",
            "link": "https://www.moneycontrol.com/news/business/companies/tpg-seals-deal-to-acquire-35-stake-in-serum-institute-schott-pharma-jv-13014205.html",
            "description": "On November 28, Moneycontrol was the first to report that billionaire Adar Poonawalla-led Serum Institute had agreed to sell 30-40 percent stake held by the top vaccine maker in SCHOTT Pharma to the US private equity firm.",
            "pubDate": "2025-05-06T05:44:51.247194"
        },
        {
            "title": "Indian Hotels Company: Healthy Q4FY25 results; strong growth prospects",
            "link": "https://www.moneycontrol.com/news/business/moneycontrol-research/indian-hotels-company-healthy-q4fy25-results-strong-growth-prospects-13014070.html",
            "description": "IHCL, with its leadership position and a comprehensive portfolio, is well-positioned to gain from the industry upcycle.",
            "pubDate": "2025-05-06T05:44:51.247278"
        },
        {
            "title": "Cummins India shares fall 5 percent after parent withdraws 2025 guidance over tariff turmoil",
            "link": "https://www.moneycontrol.com/news/business/markets/cummins-india-shares-fall-5-percent-after-parent-withdraws-2025-guidance-over-tariff-turmoil-13014090.html",
            "description": "Citing 'growing economic uncertainty', Cummins Inc said it is not providing an outlook for revenue or profitability for the rest of 2025.",
            "pubDate": "2025-05-06T05:44:51.247346"
        },
        {
            "title": "Utkarsh Small Finance Bank: Why this stock is for risk-takers?",
            "link": "https://www.moneycontrol.com/news/business/moneycontrol-research/utkarsh-small-finance-bank-why-this-stock-is-for-risk-takers-13014002.html",
            "description": "Lower default, better recovery expected as micro-finance cycle turns around",
            "pubDate": "2025-05-06T05:44:51.247412"
        },
        {
            "title": "Pharma shares sulk on Trump's plan to reduce reliance on foreign-made medicines",
            "link": "https://www.moneycontrol.com/news/business/markets/pharma-shares-sulk-on-trump-s-plan-to-reduce-reliance-on-foreign-made-medicines-13014028.html",
            "description": "The USFDA is expected to submit a report within 180 days of the order, reviewing regulations and guidance on development of domestic pharma manufacturing. The Executive Order also proposes steps to eliminate ' duplicative or unnecessary requirements' in regulations.",
            "pubDate": "2025-05-06T05:44:51.247477"
        },
        {
            "title": "Why this growth leader from Indian IT is a must add",
            "link": "https://www.moneycontrol.com/news/results/why-this-growth-leader-from-indian-it-is-a-must-add-13013987.html",
            "description": "Revenue traction, sequential margin improvement, and record order flows set the stage for earnings growth",
            "pubDate": "2025-05-06T05:44:51.247548"
        },
        {
            "title": "President Trump signs Executive Order to ramp up US prescription drug manufacturing",
            "link": "https://www.moneycontrol.com/news/business/president-trump-signs-executive-order-to-ramp-up-us-prescription-drug-manufacturing-13013854.html",
            "description": "The order directs the USFDA to reduce the time it takes to approve domestic pharmaceutical manufacturing facilities, get rid of unnecessary requirements, and provide support to domestic manufacturers to bring up facilities.",
            "pubDate": "2025-05-06T05:44:51.247612"
        }
    ]
}